During the NIH Global Doctoral Partnerships 2014 Annual Research Colloquium, three members of the NIH Oxford/Cambridge Scholars Program were recognized for their outstanding research. They are:
Prantik Kundu – Innovation Award for Novel Solutions in Biology or Medicine for discoveries of unusual importance, application, or magnitude that make use of new or unusual methods, paradigms or approaches to solve important problems in biology or medicine
Mentors: Dr. Peter Bandettini(NIMH) and Dr. Ed Bullmore at Cambridge. Studying the dynamics of brain function measured by fMRI. In a recent PNAS paper, Prantik developed a novel method to improve the signal of fMRI brain images using a multiecho technique, leading to improvement in connectivity maps of the brain to better understand and map neural activity. A recent graduate, Prantik will be starting a faculty position at Mount Sinai this Fall.
Katherine Deigan Warner – Basic Science Award for Discoveries in Cellular and Molecular Biology for discoveries of fundamental cellular, molecular, or genetic processes using model systems that advance scientific understanding of biological processes in higher organisms
Mentors: Dr. Adrian Ferre-D’Amare(NHLBI) and Dr. Chris Abell, Cambridge. Understanding the structural and functional relationship of RNA riboswitches. In a recent Chemical Biology paper, Katherine studied RNA structural changes upon site-specific binding of various small molecule fragments, aiding in understanding how potential drug candidates can inhibit RNA riboswitches function by structural changes induced upon drug binding.
Mentors: Dr. Forbes Porter (NICHD) and Prof. Frances Platt, Oxford. How cholesterol affects childhood development. A recent Clinical Genetics paper, with Chris as the senior corresponding author, focused on using DNA exome sequencing to understand the population genetics and carrier frequency of a rare genetic disease, Smith-Lemli-Opitz Syndrome. Demonstrating the importance of exome sequencing in translational research to determine more accurate risk assessment of genetic diseases.